CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 56 filers reported holding CARDIFF ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 18.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,168 | -49.2% | 840 | -46.3% | 0.00% | – |
| Q2 2023 | $2,300 | -10.9% | 1,565 | 0.0% | 0.00% | – |
| Q1 2023 | $2,582 | +29.1% | 1,565 | +22.2% | 0.00% | – |
| Q4 2022 | $2,000 | -33.3% | 1,281 | -9.3% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 1,412 | -15.8% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 1,677 | -24.0% | 0.00% | – |
| Q1 2022 | $5,000 | -75.0% | 2,208 | -34.6% | 0.00% | – |
| Q4 2021 | $20,000 | +17.6% | 3,374 | +36.4% | 0.00% | – |
| Q3 2021 | $17,000 | -5.6% | 2,474 | -4.6% | 0.00% | – |
| Q2 2021 | $18,000 | -85.6% | 2,593 | -80.9% | 0.00% | – |
| Q1 2021 | $125,000 | +220.5% | 13,549 | +518.4% | 0.00% | – |
| Q4 2020 | $39,000 | -22.0% | 2,191 | -37.4% | 0.00% | – |
| Q3 2020 | $50,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |